期刊论文详细信息
American Journal of Immunology
The Role of Treg Cells in the Cancer Immunological Response | Science Publications
Zhi-Zhang Yang1  Stephen M. Ansell1 
关键词: CD4+CD25+;    Treg cells;    Foxp3;    cancer;    tumor immunity;    immune response;   
DOI  :  10.3844/ajisp.2009.17.28
学科分类:过敏症与临床免疫学
来源: Science Publications
PDF
【 摘 要 】

Problem statement: T cell-mediated immunosuppression has been observed for decades without clarification as to which factor was responsible for this observation. The identification of CD4+CD25+ regulatory T (Treg) cells represents a milestone in the filed of immunology and provides an explanation for T-cell-mediated immunosuppression. Although Treg cells were originally identified for their ability to prevent organ-specific autoimmune disease in mice, emerging evidence suggests that Treg cells play a pivotal role in tumor immunity and contribute to tumor growth and progression, thereby having an important impact on the outcome of cancer patients. Approach: This article reviewed the medical literature to describe how Treg cells affect anti-tumor immunity. Results: Treg cells suppressed anti-tumor immunity by inhibiting the effector functions of tumor-specific T cells and NK cells. Importantly, tumor cells played an active role in recruiting and generating Treg cells and creating a suppressive tumor microenvironment. Strategies to deplete Treg cells or inhibit their function had yielded promising results by enhancing anti-tumor immunity in experimental studies as well as clinical practice. Conclusion: A better understanding of the pathophysiology of Treg cells not only increased our knowledge in a variety of aspects of immunology but also potentially benefited cancer patients.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201912010159854ZK.pdf 148KB PDF download
  文献评价指标  
  下载次数:6次 浏览次数:12次